Comprehensive prediction of urolithiasis based on clinical factors, blood chemistry and urinalysis: UROLITHIASIS score

Abstract Comprehensive prediction of urolithiasis using available factors obtained in the emergency department may aid in patient-centered diagnostic imaging decisions. This retrospective study analyzed the clinical factors, blood chemistry and urine parameters of patients who underwent nonenhanced urinary computed tomography for suspected urolithiasis. A scoring system was developed from a logistic regression model and was […]

Impact of fractionated cisplatin and radiation treatment on cell growth and accumulation of DNA damage in two normal cell types differing in origin

Abstract Evidence on the impact of chemotherapy on radiotherapy-induced second malignant neoplasms is controversial. We estimated how cisplatin modulates the in vitro response of two normal cell types to fractionated radiation. AHH-1 lymphoblasts and VH10 fibroblasts were irradiated at 1 Gy/fraction 5 and 3 times per week during 12 and 19 days, respectively, and simultaneously treated with […]

UnityPoint Health community blood draw screenings Thursday

UnityPoint Health Trinity Healthy Living Department is holding community blood draw screenings from 6:45 to 11:45 a.m. Thursday in the Diabetes Center/Healthy Living Department by appointment only. The chemistry panel, including lipid panel is $25. A fast for 10 to 12 hours is required. The thyroid stimulating hormone (TSH) is $25. The hemoglobin A1C is […]

Coming up: 12th annual Never Forget Blood Drive

MADISON, Wis. — The American Red Cross and the Madison fire and police departments will host the 12th annual Never Forget Blood Drive Monday, September 11.  The first ever memorial drive was in 2012. Since then, Red Cross has collected nearly one thousand donations, helping people that have cancer, need a blood transfusion, or have […]

Study documents devastating effects of Long COVID two years after infection

A study recently published in Nature Medicine comprehensively assessed for the first time a broad range of impacts of COVID-19 up to two years after SARS-CoV-2 infection. It found that of 80 long-term consequences or sequelae of the disease, individuals with past infection remained at risk for 48 or 60 percent of them at two […]

Alphatec Holdings (ATEC): A Modestly Undervalued Gem in the Medical Technology Sector

Alphatec Holdings Inc ( ATEC, Financial) is a medical technology company that focuses on the design, development, and advancement of products for the surgical treatment of spinal disorders. Despite recent market fluctuations, with a daily loss of 6.89% and a 3-month loss of 7.19%, the company remains a strong contender for investment. With a Loss […]

Subcutaneous Epcoritamab Elicits Durable Responses in Relapsed/Refractory LBCL

Yasmin H. Karimi, MD Subcutaneous epcoritamab-bysp (Epkinly) produced deep and durable complete remissions in patients with relapsed or refractory large B-cell lymphoma (LBCL), with complete responders having favorable long-term outcomes, according to updated data from the phase 1/2 EPCORE NHL-1 trial (NCT03625037) presented during the 2023 SOHO Annual Meeting.1 At a median follow-up of 20 […]

Speech Therapy Services Market 2023-2030 | A Sneak Peek into Industry Trends and Dominate the Digital Landscape

Introducing Our Latest Speech Therapy Services Market Research Report (96 pages Report) Unveiling In-Depth Analysis of Industry Trends, Growth, and Opportunities: The Speech Therapy Services Market 2023-2030 | Medical Care | The Speech Therapy Services Market is an evolving and expanding industry that is gaining traction in various sectors. The industry is expected to undergo […]

Dr Nastoupil on the Investigation of Liso-Cel in Relapsed/Refractory Follicular Lymphoma

Loretta J. Nastoupil, MD, an associate professor, director of the Lymphoma Outcomes Database, and the section chief of New Drug Development in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, discusses the safety and efficacy data from the phase 2 TRANSCEND FL trial (NCT04245839) evaluating lisocabtagene […]